Your account is not claimed yet. You can sign up with ORCID to claim your account.

Stijn L W Koolen

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Drug Administration

Prostate Cancer

Top Venues

Clinical pharmacokinetics

International journal of nanomedicine

Molecular cancer therapeutics

Erasmus MC

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus MC Oct 1o 2015

Netherlands

Hospital pharmacist & Clinical pharmacologist :: Medical Oncology & Hospital pharmacy

Publications

Maud B A van der Kleij, Niels A D Guchelaar, Ron H J Mathijssen, Jurjen Versluis, Alwin D R Huitema, Stijn L W Koolen, Neeltje Steeghs
Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology. Clinical pharmacokinetics (2023)
Ruben A G van Eerden, Nikki S IJzerman, Milan van Meekeren, Esther Oomen-de Hoop, Niels A D Guchelaar, Andrea M W Visser, Maja Matic, Ron H N van Schaik, Peter de Bruijn, Dirk-Jan A R Moes, Pieter A Jobse, Hans Gelderblom, Alwin D R Huitema, Neeltje Steeghs, Ron H J Mathijssen, Stijn L W Koolen, null null
CYP3A4*22 Genotype-Guided Dosing of Kinase Inhibitors in Cancer Patients. Clinical pharmacokinetics (2023)
Stefan A J Buck, Annelies Van Hemelryk, Corrina de Ridder, Debra Stuurman, Sigrun Erkens-Schulze, Sem Van 't Geloof, Wilma J Teubel, Stijn L W Koolen, Elena S Martens-Uzunova, Martin E van Royen, Ronald de Wit, Ron H J Mathijssen, Thomas A Kirkland
Darolutamide added to docetaxel augments antitumor effect in models of prostate cancer through cell cycle arrest at the G1-S transition. Molecular cancer therapeutics (2023)
Ruben A G van Eerden, Ron H J Mathijssen, Stijn L W Koolen
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer. International journal of nanomedicine 15 (2020)